VKTXViking Therapeutics, Inc

CSNasdaq (XNAS)·USD

Identity

Security key: 23369
Ticker: VKTX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2015-04-29
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: VKTX

Detail

Enriched 2026-08-14 20:47

Market cap: $3,968,532,916.74
Shares outstanding (class): 116,652,937
Shares outstanding (weighted): 116,652,937
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 65
Location: SAN DIEGO, CA
Homepage: https://www.vikingtherapeutics.com
Description: Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Market cap and share counts drift.

Funds holding this security

128 funds · 133 positions · $459.90M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$114.09M	0.01%	3,506,272 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$82.36M	0.05%	2,531,020 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$77.09M	1.04%	2,369,189 NS	FIGI
VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS	VBK	$46.05M	0.12%	1,415,090 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$42.02M	0.05%	1,291,213 NS	FIGI
iShares Russell Mid-Cap ETF iShares Trust	IWR	$13.66M	0.03%	419,698 NS	FIGI
Nomura Healthcare Fund Delaware Group Equity Funds IV	—	$10.74M	1.62%	330,100 NS	FIGI
Wasatch Ultra Growth Fund WASATCH FUNDS TRUST	—	$9.76M	2.43%	299,841 NS	FIGI
iShares Russell 1000 Value ETF iShares Trust	IWD	$7.44M	0.01%	228,611 NS	FIGI
JPMorgan Small Cap Growth Fund JPMorgan Trust II	—	$6.85M	0.31%	210,651 NS	FIGI
Fidelity U.S. Equity Central Fund Fidelity Central Investment Portfolios LLC	—	$5.37M	0.03%	165,000 NS	FIGI
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$5.01M	0.01%	153,899 NS	FIGI
VIP Growth Opportunities Portfolio Variable Insurance Products Fund III	—	$4.95M	0.12%	151,989 NS	FIGI
iShares Russell Mid-Cap Value ETF iShares Trust	IWS	$4.72M	0.03%	145,093 NS	FIGI
LVIP American Century Capital Appreciation Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	—	$4.25M	1.01%	130,497 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERVKTX
FIGI_COMPOSITEBBG006LGV869
FIGI_SHARE_CLASSBBG006LGV887
CIK0001607678
ISINUS92686J1060
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.85
Model: deepseek
Rationale: Viking Therapeutics is a clinical-stage biopharmaceutical company developing drugs for metabolic disorders, fitting the biotechnology industry.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.